TY - JOUR
T1 - Oxidative stress and predominant Aβ42(43) deposition in myopathies with rimmed vacuoles
AU - Tateyama, M.
AU - Takeda, A.
AU - Onodera, Y.
AU - Matsuzaki, M.
AU - Hasegawa, Y.
AU - Nunomura, A.
AU - Hirai, K.
AU - Perry, G.
AU - Smith, M. A.
AU - Itoyama, Y.
N1 - Funding Information:
Acknowledgement We wish to thank to Dr. T. Iwatsubo for informative comments. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare (A.T.). We are grateful to Mr. Brent Bell for reading the manuscript.
PY - 2003/6/1
Y1 - 2003/6/1
N2 - This study was undertaken to determine the C terminus of amyloid β protein (Aβ), accumulated in vacuolated muscle fibers, and compare these findings to the level of oxidative stress. Eight patients with myopathies characterized by rimmed vacuoles (RVs) were analyzed. Monoclonal antibodies specific to Aβ40 or Aβ42(43) revealed that the Aβ42(43) immunoreactivity was solely distributed in the vacuolated muscle fibers, and that only a part was also immunopositive for anti-Aβ40. Quantitative analyses in four specimens, in which eight or more vacuolated muscle fibers were observed, revealed that the mean incidence of Aβ42(43)-positive muscle fibers was 79.5±6.2% in total vacuolated muscle fibers, whereas that of the Aβ40-positive fibers was 42.9±12.6%. The predominance of Aβ42(43) deposition was statistically significant (P<0.05). Aβ deposition was then compared with the distribution of oxidative nucleic acid damage in muscle fibers using a monoclonal antibody against 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanosine (8OHdG&G). The cytoplasmic staining for anti-8OHdG&G was found not only in vacuolated muscle fibers, but also in other muscle fibers including morphologically normal ones. Positive staining was completely abolished by RNase pretreatment and, thus, was suggested to reflect an increase of cellular RNA oxidation. The distribution of 8OHdG&G was much broader than the Aβ deposition. These data suggest that Aβ42(43) is predominantly involved in the pathogenesis of muscle fiber degeneration with RVs, and that oxidative damage may precede Aβ deposition in muscle fibers and play a key role in the pathomechanism of myopathies with RVs.
AB - This study was undertaken to determine the C terminus of amyloid β protein (Aβ), accumulated in vacuolated muscle fibers, and compare these findings to the level of oxidative stress. Eight patients with myopathies characterized by rimmed vacuoles (RVs) were analyzed. Monoclonal antibodies specific to Aβ40 or Aβ42(43) revealed that the Aβ42(43) immunoreactivity was solely distributed in the vacuolated muscle fibers, and that only a part was also immunopositive for anti-Aβ40. Quantitative analyses in four specimens, in which eight or more vacuolated muscle fibers were observed, revealed that the mean incidence of Aβ42(43)-positive muscle fibers was 79.5±6.2% in total vacuolated muscle fibers, whereas that of the Aβ40-positive fibers was 42.9±12.6%. The predominance of Aβ42(43) deposition was statistically significant (P<0.05). Aβ deposition was then compared with the distribution of oxidative nucleic acid damage in muscle fibers using a monoclonal antibody against 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanosine (8OHdG&G). The cytoplasmic staining for anti-8OHdG&G was found not only in vacuolated muscle fibers, but also in other muscle fibers including morphologically normal ones. Positive staining was completely abolished by RNase pretreatment and, thus, was suggested to reflect an increase of cellular RNA oxidation. The distribution of 8OHdG&G was much broader than the Aβ deposition. These data suggest that Aβ42(43) is predominantly involved in the pathogenesis of muscle fiber degeneration with RVs, and that oxidative damage may precede Aβ deposition in muscle fibers and play a key role in the pathomechanism of myopathies with RVs.
KW - 8-Hydroxyguanosine
KW - Amyloid beta protein
KW - Distal myopathy with rimmed vacuoles
KW - Oxidative stress
KW - Rimmed vacuoles
UR - http://www.scopus.com/inward/record.url?scp=0038451600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038451600&partnerID=8YFLogxK
U2 - 10.1007/s00401-003-0685-2
DO - 10.1007/s00401-003-0685-2
M3 - Article
C2 - 12734664
AN - SCOPUS:0038451600
SN - 0001-6322
VL - 105
SP - 581
EP - 585
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 6
ER -